Please login to the form below
Merging global and local pharmacovigilance operations into a successful integrated approach
By Alisa Hummings
Digital technology: a significant change in healthcare innovation
By Megan Allen
Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
By Stephen Jones, Heather Bennett and Agustin Ramirez
Why pharma needs to ‘walk the talk’ on improving the greener patient journey
By Kate Harrison
Implicit bias in treatment impacts clinical trials too
By Ash Rishi
-
Implicit bias in treatment impacts clinical trials tooBy Ash Rishi
-
Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycleBy Gary Schneider, Koen Degeling and Kathy Belk
-
The power of mentoring: creating connectionsBy Kerri Bednarcik and Nicki Davison
-
Reimbursement ≠ patient accessBy Toby Gunner
-
Antimicrobial resistance – the silent pandemicBy Isabella Talbot
-
Who needs to be trusted anyway?By Luke Cripps
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Takeda’s dengue vaccine receives MHRA approval for those aged four years and older
- Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
- Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients
- NHS urges people yet to receive their COVID-19 booster to come forward
- Biosimilars and beyond: innovating for improved patient outcomes
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Why female mentorship is so powerful in pharma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Europe’s cancer community publishes new report on transforming patient care
- Digital technology: a significant change in healthcare innovation
- Assessing the value of interim analyses in clinical trials
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Biosimilars and beyond: innovating for improved patient outcomes
- How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
